circulatorydisorders-150815073205-lva1-app6892_241007_192506.pdf

Disorder Of circulatory system

1. Circulatory Disorders
Done By : Dr. RashaKhalil

2. •Topics included:
•Hyperemia and Congestion
•Hemorrhage
•Thrombosis

3. Hyperemia and Congestion
•Hyperemia and congestion both
refer to an increase in blood volume
within a tissue but they have
different underlying mechanisms.

5. •Hyperemia:
•Is an activeprocess resulting from arteriolar dilation
and increased blood inflow, as occurs at sites of
inflammation or in exercising skeletal muscle.
•Characteristics:
1.Redder than normal because of engorgement with
oxygenatedblood.
2.Warmerthan usual
3.Swollen
4.Pulse may be felt readily − due to the elastic recoil of
arterioles, hyperemia is dissipated after death in skin
and mucous membranes and is usually not apparent
post-mortem

6. •Causes:
•physiologic: in response to increased
demands for nutrients because of work being
done .
•pathologic: in response to certain vasodilator
chemicals and neurogenicstimuli associated
with irritation of tissue.

7. •Congestion:
•Is a passiveprocess resulting from impaired outflow of venous
blood from a tissue. It can occur systemically, as in cardiac
failure, or locally as a consequence of an isolated venous
obstruction.
•Characteristics:
1.An abnormal blue-red color (cyanosis) that stems from the
accumulation of deoxygenatedhemoglobin in the affected area.
2.Swollen .
3.Coolerthan normal
4.After death the color becomes even more dark blue and the cut
surface of such tissues oozes blood freely
5.If chronic, the tissue may have a brown color
•In long-standing chronic congestion, inadequate tissue perfusion
and persistent hypoxia may lead to parenchymalcell death and
secondary tissue fibrosis, and the elevated intravascular pressures
may cause edema or sometimes rupture capillaries, producing focal
hemorrhages.

8. •Causes:
1)Peripheral
a.obstructive -e.g., thrombus or embolus
b.constrictive -e.g., collapsing veins
2)Central-due to heart failure, which may be caused
by:
conditions associated with weakened ventricular
muscle
conditions causing ventricles to pump against
increased resistance (e.g., valvularstenosis,
hypertension)
conditions that increase volume of blood delivered to
ventricles (leaky valves, septaldefects)

9. •MORPHOLOGY
•Cut surfaces of hyperemic or congested tissues
feel wet and typically ooze blood.
•On microscopic examination,
•Acutepulmonary congestion is marked by
blood-engorged alveolar capillaries and variable
degrees of alveolar septaledema and intra-
alveolar hemorrhage.
•Chronic pulmonarycongestion, the septa
become thickened and fibrotic, and the alveolar
spaces contain numerous macrophages laden
with hemosiderin(“heart failure cells”) derived
from phagocytosedred cells.

10. •In acute hepatic congestion, the central vein and
sinusoids are distended with blood, and there
may even be central hepatocytedrop-out due to
necrosis. The periportalhepatocytes, better
oxygenated because of their proximity to hepatic
arterioles, experience less severe hypoxia and
may develop only reversible fatty change.
•Inchronic congestion of the liver, the central
regions of the hepatic lobules, viewed on gross
examination, are red-brown and slightly
depressed (owing to cell loss) and are
accentuated against the surrounding zones of
uncongested tan, sometimes fatty liver (nutmeg
liver).

11. •Microscopic findings include:
centrilobularhepatocytenecrosis
hemorrhage
hemosiderin-laden macrophages
•In long-standing, severe hepatic congestion
(most commonly associated with heart
failure), hepatic fibrosis (“cardiac cirrhosis”)
can develop.

12. Hemorrhage

13. •Defined:as the extravasationof blood from vessels.
•Classification:
1. Site
•1. External. Bleeding Is visible as it occurs
a.through skin wounds
b.or from a body orifice as in epistaxisor hematemesis.
•2. Internal.
a. In body cavities, e.g., hemoperitoneumand
hemothorax.
b. Interstitial, e.g., fracture hematoma.

14. 2. By size and form
• Petechiae
•Are minute (1 to 2 mm in diameter) hemorrhages into skin, mucous
membranes, or serosalsurfaces
•Causes include:
low platelet counts (thrombocytopenia),
defective platelet function,
loss of vascular wall support, as in vitamin C deficiency
• Purpura
•Are slightly larger (3 to 5 mm) hemorrhages.
•Causes include :
same disorders that cause petechiae,
trauma,
vascular inflammation (vasculitis),
increased vascular fragility.

15. •Ecchymosis
•Are larger (1 to 2 cm) subcutaneous hematomas
( called bruises).
•Extravasatedred cells are phagocytosedand
degraded by macrophages;
•The characteristic color changes of a bruise are due
to :
Enzymatic conversion of hemoglobin (red-blue color)
to
Bilirubin(blue-green color)
And eventually hemosiderin(golden-brown).

17. 3. Type of disrupted vessel
•1. Arterial… blood is bright red and comes in pulsatilejets.
•2. Venous... blood is dark red and comes in a steady flow.
•3. Capillary...bleeding occurs as diffuse ooze of bright red
blood.
4. Timing in relation to trauma
•1. Primary hemorrhage occurs at the time of trauma.
•2. Reactionary hemorrhage occurs within 24 hours after
trauma. As the blood pressure rises due to correction of
hypovolemiaor secondary to post-operative pain, an insecure
ligature slips or a clot is dislodged.
•3. Secondary hemorrhage occurs one to two weeks after
trauma due to infection eroding a vessel wall. It can be fatal if
a large artery is Involved, (e.g., the carotid )after sloughing of
the skin flaps of a radical neck dissection.

18. •Etiology
1. Traumatic
•a. Accidental.
•b. Surgical.
•c. Interventional procedures.
2. Pathological
•a. Atherosclerotic (ruptured aortic aneurysm).
•b. Inflammatory (bleeding peptic ulcer).
•c. Neoplastic(hematuriain renal cancer).
3. Bleeding diathesis
can increase the amount of traumatic and pathological
bleeding, or cause bleeding with little or no trauma
(spontaneous haemorrhage).

19. •Physiological response to hemorrhage
•The physiological response to hemorrhage has two aims:
1.Stop the bleeding
a.Vasoconstriction and retraction of the intimaof the injured vessel.
b.Platelet plug.
c.Blood clotting.
2. Maintaining effective circulatory volume and perfusion of
critical tissues (brain and heart), at the expense of less
critical tissues (skin, skeletal muscle ). This is achieved by
neural and endocrine factors:
A. Neural factors.
A sympathoadrenaldischarge develops due to decrease in
the stimulation of arterial baroreceptors(aortic arch and
carotid sinus) and atrialstretch receptors leading to reduction
of the normal Inhibitory discharge in the vagusand
glossopharyngealnerves on the vasomotor center with
consequent stimulation of the sympathetic system.

20. The effects include:
•1. Constriction of veins, which normally contain
two-thirds of the blood volume, displaces blood
from the capacitance side of the circulation into
the heart.
•2. Constriction of arterioles raises the peripheral
resistance but this is not uniform.
•It involves mainly the arterioles of the skin and
skeletal muscle
•3. Increased rate and strength of cardiac
contraction.

22. B. Endocrine factors
1. Catecholamine discharge occurs from the adrenal
medulla and from the nerve endings throughout the
autonomic nervous system. They increase the heart
rate and myocardial contraction and cause
constriction of the arterioles of the skin, kidney and
viscera.
2. The metabolic hormones ACTH, cortisol,
growth hormone and glucagon are increased.
Insulin release is inhibited by adrenaline and
noradrenalin.

23. 3. The renin-angiotensinaldosteronesystem.
The juxtaglomerularcells of the afferent renal arterioles
secrete reninin response to renal hypoperfusion.
Reninsplits angiotensinogento angiotensinI which Is
converted to angiotensinII by a converting enzyme in the
lung.
AngiotensinII is a powerful vasoconstrictor and stimulates
sodium and water retention by a direct action on the
kidney as well as indirectly through release of aldosterone
from the zonaglomerulosaof the adrenal cortex.
Angiotensinmediated vasoconstriction takes 20 minutes
to occur, whereas baroreceptor-vasoconstriction occurs
within seconds.

25. 4. ADH (vasopressin).
•Blood loss greater than 10% stimulates ADH release.
•ADH increases the permeability of the renal collecting
tubules allowing water absorption into the hypertonic renal
medullaryinterstitium.
•With severe hemorrhage high levels of ADH also cause
vasoconstriction.
C. Transcapillaryrefill.
•Reduction of blood volume and constriction of arterioles
causes a fall in capillary hydrostatic pressure and promotes
movement of fluid from the interstitiuminto the capillaries.
•The resulting hemodilutionincreases the blood volume and
lowers its viscosity, thus improving effective circulatory
volume.

26. Effect and significance of hemorrhage:
1.According to amount and rate of blood loss
If rapid blood loss occurs (1/4 to 1/3 of the
total blood volume over a period of less than a
few hours), hypovolemicshock and perhaps
death will occur.
If slower blood loss occurs (as much as 1/2
total blood volume over weeks or months), no
serious consequences may occur because the
body compensates.

27. 2.According to site of hemorrhage
Bleeding that would be trivial in the
subcutaneous tissues can cause death if located
in the brain .
Chronic or recurrent external blood loss (e.g., due
to peptic ulcer) frequently culminates in iron
deficiency anemia as a consequence of loss of
iron in hemoglobin.
By contrast, iron is efficiently recycled from
phagocytosedred cells, so internal bleeding (e.g.,
a hematoma) does not lead to iron deficiency.

28. Thrombosis

29. •Definedas :the formation of a blood clot
within the vasculature.
•Causesof thrombus formation (Virchow’s
triad):
(1) Endothelial injury,
(2) Stasis or turbulent blood flow,
(3) Hypercoagulabilityof the blood

30. 1) Endothelial Injury
•Endothelial injury is an importantcause of thrombosis,
particularly in the heart and the arteries, where high flow
rates might otherwise impede clotting by preventing
platelet adhesion or diluting coagulation factors.
•Examplesof thrombosis related to endothelial damage
are:
The formation of thrombi in the cardiac chambers after
myocardial infarction,
Over ulcerated plaques in atherosclerotic arteries,
At sites of traumatic or inflammatory vascular injury
(vasculitis).
•Overt loss of endothelium exposes subendothelialECM
(leading to platelet adhesion), releases tissue factor, and
reduces local production of PGI2 and plasminogen
activators.

31. •Any perturbation in the dynamic balance of the
prothromboticand antithrombotic effects of endothelium
can influence clotting locally.
•Thus, dysfunctional endothelium elaborates greater
amounts of procoagulantfactors (e.g., platelet adhesion
molecules, tissue factor) and synthesizes lesser amounts of
anticoagulant molecules (e.g., thrombomodulin, PGI2, t-
PA).
•Endothelial dysfunction can be induced by a variety of
insults, including :
1.Hypertension,
2.Turbulent blood flow,
3.Bacterial products
4.Radiation injury,
5.Metabolic abnormalities such as homocystinuriaand
toxins absorbed from cigarette smoke.

32. 2) Abnormal Blood Flow
•
•Turbulence contributes to arterial and cardiac
thrombosis by causing
1.endothelial injury or dysfunction,
2.forming countercurrents and local pockets of
stasis.
•Stasis
Is a majorfactor in the development of venous thrombi.
Under conditions of normal laminar blood flow, platelets
(and other blood cells) are found mainly in the center of
the vessel lumen, separated from the endothelium by a
slower-moving layer of plasma.

33. •Stasisand turbulentblood flow have the following
effects:
1.Both promote endothelial cell activation and
enhanced procoagulantactivity, in part through flow-
induced changes in endothelial gene expression.
2.Stasis allows platelets and leukocytes to come into
contact with the endothelium when the flow is
sluggish.
3.Stasis also slows the washout of activated clotting
factors and impedes the inflow of clotting factor
inhibitors.

34. •Turbulent and static blood flow contribute to
thrombosis in a number of clinical settings
including:
Ulcerated atherosclerotic plaques not only
expose subendothelialECM but also cause
turbulence.
Abnormal aortic and arterial dilations called
aneurysmscreate local stasis and consequently a
fertile site for thrombosis.
Acute myocardial infarction results in focally
noncontractilemyocardium.

35. Ventricular remodeling after more remote infarction can
lead to aneurysm formation. In both cases, cardiac mural
thrombi are more easily formed due to the local blood
stasis
Mitral valve stenosis(e.g., after rheumatic heart disease)
results in left atrialdilation. In conjunction with atrial
fibrillation, a dilated atrium is a site of profound stasis
and a prime location for the development of thrombi.
Hyperviscositysyndromes (such as polycythemia)
increase resistance to flow and cause small vessel stasis;
The deformed red cells in sickle cell anemia cause
vascular occlusions, and the resultant stasis also
predisposes to thrombosis.

36. 3) Hypercoagulability
•Hypercoagulabilitycontributes infrequently to
arterial or intracardiacthrombosis but is an
important underlying risk factor for venous
thrombosis.
•Definedas any alteration of the coagulation
pathways that predisposes affected persons to
thrombosis,
•Divided into:
1.Primary (genetic) disorders
2.Secondary (acquired) disorders

37. 1) Primary (inherited) hypercoagulability
Most often is caused by mutations in the factor V and
prothrombingenes:
•Approximately 2% to 15% of whites carry a specific factor V
mutation (called the Leiden mutation).
•The mutation alters an amino acid residue in factor V and
renders it resistant to protein C.
•Thus, an important antithrombotic counter-regulatory
mechanism is lost.
•Heterozygotescarry a 5-fold increased risk for venous
thrombosis, with homozygoteshaving a 50-fold increased
risk.
•Asingle-nucleotide substitution (G to A) in the 3′-
untranslated region of the prothrombingene is a fairly
common allele
•This variant results in increased prothrombintranscription
and is associated with a nearly threefold increased risk for
venous thromboses.

38. •Less common primary hypercoagulablestates
include:
Inherited deficiencies of anticoagulants such as
antithrombinIII
protein C
protein S
•Affected patients typically present with venous
thrombosis and recurrent thromboembolismin
adolescence or early adult life.

39. 2)Secondary (acquired) hypercoagulability
In some situations (e.g., cardiac failure or trauma), stasis or
vascular injury may be the most important factor.
The hypercoagulabilityassociated with oral contraceptive
use and the hyperestrogenicstate of pregnancymay be
related to increased hepatic synthesis of coagulation factors
and reduced synthesis of antithrombinIII
In disseminated cancers, release of procoagulanttumor
products (e.g., mucinfrom adenocarcinoma) predisposes to
thrombosis.
The hypercoagulabilityseen with advancing age has been
attributed to increased platelet aggregation and reduced
release of PGI2 from endothelium.
Smokingand obesity promote hypercoagulabilityby unknown
mechanisms.

40. •Two significant situations are:
1.Heparin-induced thrombocytopenic (HIT) syndrome.
Thissyndrome occurs in up to 5% of patients treated with
unfractionatedheparin (for therapeutic anticoagulation).
It is marked by the development of autoantibodiesthat bind
complexes of heparin and platelet membrane protein (platelet
factor-4)
•Although the mechanism is unclear, it appears that these antibodies
may also bind similar complexes present on platelet and endothelial
surfaces, resulting in platelet activation, aggregation, and
consumption (hence thrombocytopenia), as well as causing
endothelial cell injury.
The overall result is a prothromboticstate, even in the face of
heparin administration and low platelet counts.
Newerlow-molecular-weight fractionated heparin preparations
induce autoantibodiesless frequently but can still cause thrombosis
if antibodies have already formed.

41. 2) Antiphospholipidantibody syndrome.
•This syndrome has manifestations, including :
1.recurrent thrombosis
2.repeated miscarriages,
3.cardiac valve vegetations,
4.and thrombocytopenia;
•It is associated with autoantibodiesdirected against
anionic phospholipids (e.g., cardiolipin) or—more
accurately—plasma protein antigens that are unveiled by
binding to such phospholipids (e.g., prothrombin).
•In vivo, these antibodies induce a hypercoagulablestate,
perhaps by inducing endothelial injury, by activating
platelets or complement directly, or by interacting with
the catalytic domains of certain coagulation factors.

42. •In vitro(in the absence of platelets and endothelium),
however, the antibodies interfere with phospholipid
complex assembly, thereby inhibiting coagulation
(hence the designation lupus anticoagulant).
•Patients with antiphospholipidantibody syndrome fall
into two categories:
1.Many have secondary antiphospholipidsyndrome
due to a well-defined autoimmune disease, such as
systemic lupus erythematosus
2.The remainder of these patients exhibit only the
manifestations of a hypercoagulablestate without
evidence of another autoimmune disorder (primary
antiphospholipidsyndrome).

43. •MORPHOLOGY
•Thrombi can develop anywhere in the cardiovascular
system.
•Arterial or cardiac thrombi typically arise at sites of
endothelial injury or turbulence;
•venous thrombi characteristically occur at sites of
stasis.
•Thrombi are focally attached to the underlying vascular
surface and tend to propagate towardthe heart; thus,
arterial thrombi grow in a retrograde direction from
the point of attachment,
•while venous thrombi extend in the direction of blood
flow. The propagating portion of a thrombus tends to
be poorly attached and therefore prone to
fragmentation and migration through the blood as an
embolus.

44. •Thrombi occurring in heartchambers or in the aortic
lumen are designated mural thrombi. Abnormal
myocardial contraction (arrhythmias, dilated
cardiomyopathy, or myocardial infarction) or
endomyocardialinjury (myocarditis, catheter trauma)
promote cardiac mural thrombi , while ulcerated
atherosclerotic plaques and aneurysmaldilation
promote aortic thrombosis
•Arterial thrombi are typically relatively rich in
platelets, as the processes underlying their
development (e.g., endothelial injury) lead to platelet
activation. Although usually superimposed on a
ruptured atherosclerotic plaque, other vascular injuries
(vasculitis, trauma) can also be causal

45. •Venous thrombi (phlebothrombosis)
•Frequently propagate some distance toward the
heart, forming a long cast within the vessel lumen
that is prone to give rise to emboli.
•An increase in the activity of coagulation factors
is involved in the genesis of most venous
thrombi, with platelet activation playing a
secondary role.
•The veins of the lower extremities are most
commonly affected (90%of venous thrombosis);

46. •Thrombi on heart valves are called vegetations.
•Bacterialor fungal blood-borne infections can
cause valve damage, leading to the development
of large thrombotic masses (infective
endocarditis)
•Sterile vegetations also can develop on
noninfectedvalves in hypercoagulablestates—
the lesions of so-called nonbacterial thrombotic
endocarditis

48. Venous Thrombosis (Phlebothrombosis).
•Most venous thrombi occur in either the
superficial or the deep veins of the leg.
•Superficial venous thrombi usually arise in
the saphenoussystem, particularly in the
setting of varicose viens; these rarely embolize
but can be painful and can cause local
congestion and swelling from impaired venous
outflow, predisposing the overlying skin to
development of infections and varicose ulcers

49. •Deep venous thrombosis (DVT)
Occur in the larger leg veins at or above the knee joint
(e.g., popliteal, femoral, and iliac veins)
Are more serious because they are prone to embolize.
Although such DVTs may cause local pain and edema,
the venous obstruction often is circumvented by
collateral channels.
Consequently, DVTs are entirely asymptomatic in
approximately 50% ofpatients and are recognized only
after they have embolizedto the lungs.

50. Deep venous thromboses (DVT)

51. •Lower-extremity DVTs are associated with stasis and
hypercoagulablestates
Common predisposing factors include:
1.Patient factors
Age
Previous DVT or PE
Immobility
Obesity
Pregnancy
Thrombophilia(eg.proteinC & protein S deficiencies,
lupus anticoagulant & factor v leiden)
Oral contraceptive pill

52. 2. Factors involving the disease or surgical
procedure:
Trauma and surgery, especially of the pelvis and
lower limb
Malignancy, especially pelvic and abdominal
MI
Congestive heart failure
Polycythemia
Inflammatory bowel disease
Nephroticsyndrome
Length of operation

53. •Outcomes of DVT
Pulmonary embolism
Post_phlebiticlimb
Resolution without complications
•Treatment of DVT
Analgesia
Graduated compression stocking
Anticoagulation with heparin (LMW)
Long_termanticoagulation is undertaken with
warfarin
Cavalfilter
Fibrinolyticagents (in very exrensiveDVT ,but not
after major surgery)

54. •Fate of the Thrombus
•If a patient survives an initial thrombotic
event, over the coming days to weeks the
thrombus evolves through some combination
of the following four processes:
1.Propagation.
2.Embolization.
3.Dissolution
4.Organization and recanalization.

55. 1)Propagation.
•Propagation of additional platelets and fibrin, increasing the odds of
vascular occlusion or embolization.
2)Embolization.
•Part or all of the thrombus is dislodged and transported elsewhere
in the vasculature.
3)Dissolution.
If a thrombus is newly formed, activation of fibrinolyticfactors
may lead to its rapid shrinkage and complete dissolution.
With older thrombi, extensive fibrin polymerization renders the
thrombus substantially more resistant to plasmin-induced
proteolysis, and lysisis ineffective..
This acquisition of resistance to lysishas clinical significance, as
therapeutic administration of fibrinolyticagents (e.g., t-PA in the
setting of acute coronary thrombosis) generally is not effective
unless given within a few hours of thrombus formation.

56. 4) Organization and recanalization.
•Older thrombi become organizedby the ingrowthof endothelial
cells, smooth muscle cells, and fibroblasts into the fibrin-rich
thrombus
•In time, capillary channels are formed that—to a limited extent—
create conduits along the length of the thrombus, thereby
reestablishing the continuity of the original lumen.
•Further recanalizationcan sometimes convert a thrombus into a
vascularizedmass of connective tissue that is eventually
incorporated into the wall of the remodeled vessel.
•Occasionally, instead of organizing, the center of a thrombus
undergoes enzymatic digestion, presumably because of the release
of lysosomalenzymes from entrapped leukocytes.
•If bacterial seeding occurs, the contents of degraded thrombi serve
as an ideal culture medium, and the resulting infection may weaken
the vessel wall, leading to formation of a mycoticaneurysm

57. •Clinical Correlation
•Thrombi are significant because they cause obstruction
ofarteries and veins and may give rise to emboli.
1.Venous thrombi can cause congestion and edema in
vascular beds distal to an obstruction, they are most
worrisome because of their potential to embolizeto
the lungsand cause death.
2.Arterial thrombi can embolizeand cause tissue
infarction, their tendency to obstruct vessels (e.g., in
coronary and cerebral vessels) is considerably more
important.